Boehringer Ingelheim announced a partnership with Synaffix to advance antibody-drug conjugates and exercised its fourth ...

“Time-to-market is money,” says Lukas Kürten, Digital Innovation Manager at CPI. “If you’ve got a process that works, you’ve got to throw it into manufacturing, because you’ve got to milk your patent ...

There is a photo that exemplifies the paradox of Robert F. Kennedy Jr.’s nomination as secretary of the Health and Human ...

KING 5 Investigators reveal a nursery for drug-affected babies is underutilized while child overdose deaths and injuries rise ...

Back in front of Nebraska lawmakers this year is a so-called “winner-take-all” measure aimed at changing the Huskers’ ...

In a remote town 2,000 kilometres north of Perth, Floyd Churnside hopes to change the behaviour of men behind the highest ...

Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...

A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.

Many people believe that as they approach and enter retirement, they should be shedding most or all of their stocks. They assume that since the stock market can be volatile, they should stick with ...

Dr. Jack Geiger and a group of health professionals started a community health center in the Mississippi Delta, where ...